Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Current Oncology Reports

Issue 5/2016

Content (6 Articles)

Integrative Care (C Lammersfeld, Section Editor)

The Independent Effects of Strength Training in Cancer Survivors: a Systematic Review

Erik D. Hanson, Chad W. Wagoner, Travis Anderson, Claudio L. Battaglini

Genitourinary Cancers (DP Petrylak and JW Kim, Section Editors)

Improving Systemic Chemotherapy for Bladder Cancer

Tracy L. Rose, Matthew I. Milowsky

Genitourinary Cancers (DP Petrylak and JW Kim, Section Editors)

Clinical Utility of Biomarkers in Localized Prostate Cancer

Michael S. Leapman, Hao G. Nguyen, Matthew R. Cooperberg

Gynecologic Cancers (NS Reed, Section Editor)

What Is the Place of PARP Inhibitors in Ovarian Cancer Treatment?

Joyce F. Liu, Ursula A. Matulonis

Breast Cancer (B Overmoyer, Section Editor)

Vaginal Health During Breast Cancer Treatment

Sandy J. Falk, Sharon Bober

Gastrointestinal Cancers (J Meyer, Section Editor)

Pathology and Surgical Treatment of High-Grade Pancreatic Neuroendocrine Carcinoma: an Evolving Landscape

Sven-Petter Haugvik, Daniel Kaemmerer, Sebastien Gaujoux, Knut Jørgen Labori, Caroline Sophie Verbeke, Ivar Prydz Gladhaug

Apr 16
Issue: 4/2016
Jun 16
Issue: 6/2016

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits